{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:57:25Z","timestamp":1792796245929,"version":"4.5.0"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T00:00:00Z","timestamp":1724716800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T00:00:00Z","timestamp":1724716800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003093","name":"Ministry of Higher Education, Malaysia","doi-asserted-by":"publisher","award":["FRGS\/1\/2023\/SKK06\/USM\/02\/6"],"award-info":[{"award-number":["FRGS\/1\/2023\/SKK06\/USM\/02\/6"]}],"id":[{"id":"10.13039\/501100003093","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s11033-024-09877-9","type":"journal-article","created":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T12:21:32Z","timestamp":1724761292000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Current development of Fc gamma receptors (Fc\u03b3Rs) in diagnostics: a review"],"prefix":"10.1007","volume":"51","author":[{"given":"Shin Yi","family":"Gan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gee Jun","family":"Tye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ai Lan","family":"Chew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ngit Shin","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,27]]},"reference":[{"key":"9877_CR1","doi-asserted-by":"publisher","first-page":"21","DOI":"10.4236\/abb.2013.44A004","volume":"4","author":"C Rosales","year":"2013","unstructured":"Rosales C, Uribe-Querol E (2013) Fc receptors: cell activators of antibody functions. Adv Biosci Biotechnol 4:21\u201333. https:\/\/doi.org\/10.4236\/abb.2013.44A004","journal-title":"Adv Biosci Biotechnol"},{"key":"9877_CR2","doi-asserted-by":"publisher","first-page":"970","DOI":"10.3389\/fimmu.2019.00970","volume":"10","author":"DE Geraghty","year":"2019","unstructured":"Geraghty DE, Thorball CW, Fellay J, Thomas R (2019) Effect of fc receptor genetic diversity on HIV-1 Disease Pathogenesis. Front Immunol 10:970. https:\/\/doi.org\/10.3389\/fimmu.2019.00970","journal-title":"Front Immunol"},{"key":"9877_CR3","doi-asserted-by":"publisher","first-page":"3716","DOI":"10.1182\/blood-2008-09-179754","volume":"113","author":"P Bruhns","year":"2009","unstructured":"Bruhns P, Iannascoli B, England P et al (2009) Specificity and affinity of human Fc\u03b3 receptors and their polymorphic variants for human IgG subclasses. Blood 113:3716\u20133725. https:\/\/doi.org\/10.1182\/blood-2008-09-179754","journal-title":"Blood"},{"key":"9877_CR4","doi-asserted-by":"publisher","first-page":"227","DOI":"10.2174\/157339509788921229","volume":"5","author":"E Garcia-Garcia","year":"2009","unstructured":"Garcia-Garcia E, Rosales C (2009) Fc Receptor Signaling in leukocytes: role in host defense and Immune Regulation. Curr Immunol Rev Discontin 5:227\u2013242. https:\/\/doi.org\/10.2174\/157339509788921229","journal-title":"Curr Immunol Rev Discontin"},{"key":"9877_CR5","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/82_2010_86","volume":"350","author":"F Nimmerjahn","year":"2011","unstructured":"Nimmerjahn F, Ravetch JV (2011) Fc\u03b3Rs in health and disease. Curr Top Microbiol Immunol 350:105\u2013125. https:\/\/doi.org\/10.1007\/82_2010_86","journal-title":"Curr Top Microbiol Immunol"},{"key":"9877_CR6","doi-asserted-by":"publisher","first-page":"e13323","DOI":"10.1016\/j.heliyon.2023.e13323","volume":"9","author":"A Bodaghi","year":"2023","unstructured":"Bodaghi A, Fattahi N, Ramazani A (2023) Biomarkers: Promising and valuable tools towards diagnosis, prognosis and treatment of Covid-19 and other diseases. Heliyon 9:e13323. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e13323","journal-title":"Heliyon"},{"key":"9877_CR7","doi-asserted-by":"publisher","first-page":"2973","DOI":"10.1002\/sim.5403","volume":"31","author":"TR Fleming","year":"2012","unstructured":"Fleming TR, Powers JH (2012) Biomarkers and surrogate endpoints in clinical trials. Stat Med 31:2973\u20132984. https:\/\/doi.org\/10.1002\/sim.5403","journal-title":"Stat Med"},{"key":"9877_CR8","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.2147\/NDT.S112374","volume":"12","author":"DG Mert","year":"2016","unstructured":"Mert DG, Terzi H (2016) Mean platelet volume in bipolar disorder: the search for an ideal biomarker. Neuropsychiatr Dis Treat 12:2057\u20132062. https:\/\/doi.org\/10.2147\/NDT.S112374","journal-title":"Neuropsychiatr Dis Treat"},{"key":"9877_CR9","doi-asserted-by":"publisher","first-page":"2466","DOI":"10.1080\/10428194.2020.1775208","volume":"61","author":"JS Heitmann","year":"2020","unstructured":"Heitmann JS, Hagelstein I, Hinterleitner C et al (2020) Fc gamma receptor expression serves as prognostic and diagnostic factor in AML. Leuk Lymphoma 61:2466\u20132474. https:\/\/doi.org\/10.1080\/10428194.2020.1775208","journal-title":"Leuk Lymphoma"},{"key":"9877_CR10","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12873-023-00800-2","volume":"23","author":"NLM van de Ven","year":"2023","unstructured":"van de Ven NLM, Bongers SH, Spijkerman R et al (2023) Point-of-care neutrophil CD64 as a rule in diagnostic test for bacterial infections in the emergency department. BMC Emerg Med 23:28. https:\/\/doi.org\/10.1186\/s12873-023-00800-2","journal-title":"BMC Emerg Med"},{"key":"9877_CR11","doi-asserted-by":"publisher","first-page":"140","DOI":"10.3390\/pathogens9020140","volume":"9","author":"TA Hamdan","year":"2020","unstructured":"Hamdan TA, Lang PA, Lang KS (2020) The diverse functions of the ubiquitous Fc\u03b3 receptors and their Unique Constituent. FcR\u03b3 Subunit Pathogens 9:140. https:\/\/doi.org\/10.3390\/pathogens9020140","journal-title":"FcR\u03b3 Subunit Pathogens"},{"key":"9877_CR12","doi-asserted-by":"publisher","unstructured":"Nagelkerke SQ, Schmidt DE, de Haas M (2019) Genetic variation in Low-To-Medium-Affinity Fc\u03b3 receptors: functional consequences, Disease associations, and opportunities for Personalized Medicine. Front Immunol 10. https:\/\/doi.org\/10.3389\/fimmu.2019.02237","DOI":"10.3389\/fimmu.2019.02237"},{"key":"9877_CR13","doi-asserted-by":"publisher","unstructured":"Bournazos S, Wang TT, Ravetch JV (2016) The role and function of Fc\u03b3 receptors on myeloid cells. Microbiol Spectr 4. https:\/\/doi.org\/10.1128\/microbiolspec.MCHD. -0045\u20132016","DOI":"10.1128\/microbiolspec.MCHD"},{"key":"9877_CR14","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.immuni.2016.07.006","volume":"45","author":"AM Brandsma","year":"2016","unstructured":"Brandsma AM, Hogarth PM, Nimmerjahn F, Leusen JHW (2016) Clarifying the confusion between cytokine and fc receptor. Common Gamma Chain Immun 45:225\u2013226. https:\/\/doi.org\/10.1016\/j.immuni.2016.07.006","journal-title":"Common Gamma Chain Immun"},{"key":"9877_CR15","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/0092-8674(94)90115-5","volume":"76","author":"T Takai","year":"1994","unstructured":"Takai T, Li M, Sylvestre D et al (1994) FcR \u03b3 chain deletion results in pleiotrophic effector cell defects. Cell 76:519\u2013529. https:\/\/doi.org\/10.1016\/0092-8674(94)90115-5","journal-title":"Cell"},{"key":"9877_CR16","doi-asserted-by":"publisher","first-page":"464","DOI":"10.3389\/fimmu.2019.00464","volume":"10","author":"JC Anania","year":"2019","unstructured":"Anania JC, Chenoweth AM, Wines BD, Hogarth PM (2019) The human Fc\u03b3RII (CD32) family of leukocyte FcR in Health and Disease. Front Immunol 10:464. https:\/\/doi.org\/10.3389\/fimmu.2019.00464","journal-title":"Front Immunol"},{"key":"9877_CR17","doi-asserted-by":"publisher","unstructured":"Liu S, Zhang YL, Zhang LY et al (2022) FCGR2C: an emerging immune gene for predicting sepsis outcome. Front Immunol 13. https:\/\/doi.org\/10.3389\/fimmu.2022.1028785","DOI":"10.3389\/fimmu.2022.1028785"},{"key":"9877_CR18","doi-asserted-by":"publisher","first-page":"5640","DOI":"10.1182\/blood-2012-01-380121","volume":"119","author":"P Bruhns","year":"2012","unstructured":"Bruhns P (2012) Properties of mouse and human IgG receptors and their contribution to disease models. Blood 119:5640\u20135649. https:\/\/doi.org\/10.1182\/blood-2012-01-380121","journal-title":"Blood"},{"key":"9877_CR19","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.4049\/jimmunol.1003945","volume":"188","author":"J van der Heijden","year":"2012","unstructured":"van der Heijden J, Breunis WB, Geissler J et al (2012) Phenotypic variation in IgG receptors by nonclassical FCGR2C alleles. J Immunol 188:1318\u20131324. https:\/\/doi.org\/10.4049\/jimmunol.1003945","journal-title":"J Immunol"},{"key":"9877_CR20","doi-asserted-by":"publisher","first-page":"e0189498","DOI":"10.1371\/journal.pone.0189498","volume":"13","author":"OY Gorlova","year":"2018","unstructured":"Gorlova OY, Li Y, Gorlov I et al (2018) Gene-level association analysis of systemic sclerosis: a comparison of african-americans and White populations. PLoS ONE 13:e0189498. https:\/\/doi.org\/10.1371\/journal.pone.0189498","journal-title":"PLoS ONE"},{"key":"9877_CR21","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/gene.2015.60","volume":"17","author":"R Lassauni\u00e8re","year":"2016","unstructured":"Lassauni\u00e8re R, Tiemessen CT (2016) Variability at the FCGR locus: characterization in Black South africans and evidence for ethnic variation in and out of Africa. Genes Immun 17:93\u2013104. https:\/\/doi.org\/10.1038\/gene.2015.60","journal-title":"Genes Immun"},{"key":"9877_CR22","doi-asserted-by":"publisher","first-page":"657393","DOI":"10.3389\/fimmu.2021.657393","volume":"12","author":"OR Alem\u00e1n","year":"2021","unstructured":"Alem\u00e1n OR, Mora N, Rosales C (2021) The antibody receptor fc Gamma receptor IIIb induces calcium entry via transient receptor potential melastatin 2 in human neutrophils. Front Immunol 12:657393. https:\/\/doi.org\/10.3389\/fimmu.2021.657393","journal-title":"Front Immunol"},{"key":"9877_CR23","doi-asserted-by":"publisher","first-page":"280","DOI":"10.3389\/fimmu.2017.00280","volume":"8","author":"C Rosales","year":"2017","unstructured":"Rosales C (2017) Fc\u03b3 receptor heterogeneity in leukocyte functional responses. Front Immunol 8:280. https:\/\/doi.org\/10.3389\/fimmu.2017.00280","journal-title":"Front Immunol"},{"key":"9877_CR24","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1038\/s41467-017-00294-0","volume":"8","author":"SB Mkaddem","year":"2017","unstructured":"Mkaddem SB, Murua A, Flament H et al (2017) Lyn and Fyn function as molecular switches that control immunoreceptors to direct homeostasis or inflammation. Nat Commun 8:246. https:\/\/doi.org\/10.1038\/s41467-017-00294-0","journal-title":"Nat Commun"},{"key":"9877_CR25","doi-asserted-by":"publisher","first-page":"811","DOI":"10.3389\/fimmu.2019.00811","volume":"10","author":"S Ben Mkaddem","year":"2019","unstructured":"Ben Mkaddem S, Benhamou M, Monteiro RC (2019) Understanding fc receptor involvement in Inflammatory diseases: from mechanisms to New Therapeutic Tools. Front Immunol 10:811. https:\/\/doi.org\/10.3389\/fimmu.2019.00811","journal-title":"Front Immunol"},{"key":"9877_CR26","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/nri856","volume":"2","author":"T Takai","year":"2002","unstructured":"Takai T (2002) Roles of fc receptors in autoimmunity. Nat Rev Immunol 2:580\u2013592. https:\/\/doi.org\/10.1038\/nri856","journal-title":"Nat Rev Immunol"},{"key":"9877_CR27","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/S0065-2776(05)89002-9","volume":"89","author":"M Da\u00ebron","year":"2006","unstructured":"Da\u00ebron M, Lesourne R (2006) Negative signaling in fc receptor complexes. Adv Immunol 89:39\u201386. https:\/\/doi.org\/10.1016\/S0065-2776(05)89002-9","journal-title":"Adv Immunol"},{"key":"9877_CR28","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1111\/imr.12336","volume":"268","author":"A Getahun","year":"2015","unstructured":"Getahun A, Cambier JC (2015) Of ITIMs, ITAMs, and ITAMis: revisiting immunoglobulin fc receptor signaling. Immunol Rev 268:66\u201373. https:\/\/doi.org\/10.1111\/imr.12336","journal-title":"Immunol Rev"},{"key":"9877_CR29","first-page":"1432","volume":"144","author":"TW Huizinga","year":"1990","unstructured":"Huizinga TW, Dolman KM, van der Linden NJ et al (1990) Phosphatidylinositol-linked FcRIII mediates exocytosis of neutrophil granule proteins, but does not mediate initiation of the respiratory burst. J Immunol Baltim Md 1950 144:1432\u20131437","journal-title":"J Immunol Baltim Md 1950"},{"key":"9877_CR30","doi-asserted-by":"publisher","first-page":"10671","DOI":"10.1074\/jbc.270.18.10671","volume":"270","author":"PJ Vossebeld","year":"1995","unstructured":"Vossebeld PJ, Kessler J, von dem Borne AE et al (1995) Heterotypic fc gamma R clusters evoke a synergistic Ca2\u2009+\u2009response in human neutrophils. J Biol Chem 270:10671\u201310679. https:\/\/doi.org\/10.1074\/jbc.270.18.10671","journal-title":"J Biol Chem"},{"key":"9877_CR31","doi-asserted-by":"publisher","first-page":"4421","DOI":"10.1182\/blood-2011-12-401133","volume":"120","author":"K Chen","year":"2012","unstructured":"Chen K, Nishi H, Travers R et al (2012) Endocytosis of soluble immune complexes leads to their clearance by Fc\u03b3RIIIB but induces neutrophil extracellular traps via Fc\u03b3RIIA in vivo. Blood 120:4421\u20134431. https:\/\/doi.org\/10.1182\/blood-2011-12-401133","journal-title":"Blood"},{"key":"9877_CR32","doi-asserted-by":"publisher","first-page":"3124","DOI":"10.3389\/fimmu.2018.03124","volume":"9","author":"LW Treffers","year":"2018","unstructured":"Treffers LW, van Houdt M, Bruggeman CW et al (2018) Fc\u03b3RIIIb restricts antibody-dependent Destruction of Cancer cells by human neutrophils. Front Immunol 9:3124. https:\/\/doi.org\/10.3389\/fimmu.2018.03124","journal-title":"Front Immunol"},{"key":"9877_CR33","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/j.immuni.2008.04.013","volume":"28","author":"N Tsuboi","year":"2008","unstructured":"Tsuboi N, Asano K, Lauterbach M, Mayadas TN (2008) Human neutrophil fcgamma receptors initiate and play specialized nonredundant roles in antibody-mediated inflammatory diseases. Immunity 28:833\u2013846. https:\/\/doi.org\/10.1016\/j.immuni.2008.04.013","journal-title":"Immunity"},{"key":"9877_CR34","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1146\/annurev.immunol.19.1.275","volume":"19","author":"JV Ravetch","year":"2001","unstructured":"Ravetch JV, Bolland S (2001) IgG fc receptors. Annu Rev Immunol 19:275\u2013290. https:\/\/doi.org\/10.1146\/annurev.immunol.19.1.275","journal-title":"Annu Rev Immunol"},{"key":"9877_CR35","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.immuni.2019.12.006","volume":"52","author":"AB Morris","year":"2020","unstructured":"Morris AB, Farley CR, Pinelli DF et al (2020) Signaling through the inhibitory fc receptor Fc\u03b3RIIB induces CD8\u2009+\u2009T cell apoptosis to limit T cell immunity. Immunity 52:136\u2013150e6. https:\/\/doi.org\/10.1016\/j.immuni.2019.12.006","journal-title":"Immunity"},{"key":"9877_CR36","doi-asserted-by":"publisher","unstructured":"Mancardi D, Da\u00ebron M (2014) Fc Receptors in Immune responses. Ref Module Biomed Sci B978-0-12-. https:\/\/doi.org\/10.1016\/B978-0-12-801238-3.00119-7. 801238-3.00119-7","DOI":"10.1016\/B978-0-12-801238-3.00119-7"},{"key":"9877_CR37","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1002\/eji.202149766","volume":"52","author":"Y Wang","year":"2022","unstructured":"Wang Y, Kr\u00e9mer V, Iannascoli B et al (2022) Specificity of mouse and human fcgamma receptors and their polymorphic variants for IgG subclasses of different species. Eur J Immunol 52:753\u2013759. https:\/\/doi.org\/10.1002\/eji.202149766","journal-title":"Eur J Immunol"},{"key":"9877_CR38","doi-asserted-by":"publisher","first-page":"4315","DOI":"10.4049\/jimmunol.1200501","volume":"190","author":"A Lux","year":"2013","unstructured":"Lux A, Yu X, Scanlan CN, Nimmerjahn F (2013) Impact of Immune Complex size and glycosylation on IgG binding to human Fc\u03b3Rs. J Immunol 190:4315\u20134323. https:\/\/doi.org\/10.4049\/jimmunol.1200501","journal-title":"J Immunol"},{"key":"9877_CR39","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1080\/16078454.2021.2003064","volume":"26","author":"J Liang","year":"2021","unstructured":"Liang J, Xu J, You L et al (2021) Neutrophil CD64: a potential biomarker for the diagnosis of infection in patients with haematological malignancies. Hematology 26:970\u2013975. https:\/\/doi.org\/10.1080\/16078454.2021.2003064","journal-title":"Hematology"},{"key":"9877_CR40","doi-asserted-by":"publisher","first-page":"e12","DOI":"10.1016\/j.ijid.2012.07.017","volume":"17","author":"S Li","year":"2013","unstructured":"Li S, Huang X, Chen Z et al (2013) Neutrophil CD64 expression as a biomarker in the early diagnosis of bacterial infection: a meta-analysis. Int J Infect Dis IJID off Publ Int Soc Infect Dis 17:e12\u201323. https:\/\/doi.org\/10.1016\/j.ijid.2012.07.017","journal-title":"Int J Infect Dis IJID off Publ Int Soc Infect Dis"},{"key":"9877_CR41","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.ccc.2017.08.010","volume":"34","author":"TSR van Engelen","year":"2018","unstructured":"van Engelen TSR, Wiersinga WJ, Scicluna BP, van der Poll T (2018) Biomarkers in Sepsis. Crit Care Clin 34:139\u2013152. https:\/\/doi.org\/10.1016\/j.ccc.2017.08.010","journal-title":"Crit Care Clin"},{"key":"9877_CR42","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1515\/CCLM.2009.224","volume":"47","author":"JJML Hoffmann","year":"2009","unstructured":"Hoffmann JJML (2009) Neutrophil CD64: a diagnostic marker for infection and sepsis. Clin Chem Lab Med 47:903\u2013916. https:\/\/doi.org\/10.1515\/CCLM.2009.224","journal-title":"Clin Chem Lab Med"},{"key":"9877_CR43","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1177\/0968051907079101","volume":"13","author":"W van der Meer","year":"2007","unstructured":"van der Meer W, Pickkers P, Scott CS et al (2007) Hematological indices, inflammatory markers and neutrophil CD64 expression: comparative trends during experimental human endotoxemia. J Endotoxin Res 13:94\u2013100. https:\/\/doi.org\/10.1177\/0968051907079101","journal-title":"J Endotoxin Res"},{"key":"9877_CR44","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1186\/s13054-015-0972-z","volume":"19","author":"X Wang","year":"2015","unstructured":"Wang X, Li Z-Y, Zeng L et al (2015) Neutrophil CD64 expression as a diagnostic marker for sepsis in adult patients: a meta-analysis. Crit Care 19:245. https:\/\/doi.org\/10.1186\/s13054-015-0972-z","journal-title":"Crit Care"},{"key":"9877_CR45","doi-asserted-by":"publisher","first-page":"112646","DOI":"10.1016\/j.jim.2019.112646","volume":"474","author":"R Spijkerman","year":"2019","unstructured":"Spijkerman R, Hesselink L, Hellebrekers P et al (2019) Automated flow cytometry enables high performance point-of-care analysis of leukocyte phenotypes. J Immunol Methods 474:112646. https:\/\/doi.org\/10.1016\/j.jim.2019.112646","journal-title":"J Immunol Methods"},{"key":"9877_CR46","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1186\/s12879-022-07725-4","volume":"22","author":"Y Gao","year":"2022","unstructured":"Gao Y, Lin L, Zhao J et al (2022) Neutrophil CD64 index as a superior indicator for diagnosing, monitoring bacterial infection, and evaluating antibiotic therapy: a case control study. BMC Infect Dis 22:892. https:\/\/doi.org\/10.1186\/s12879-022-07725-4","journal-title":"BMC Infect Dis"},{"key":"9877_CR47","doi-asserted-by":"publisher","first-page":"13961","DOI":"10.1111\/jcmm.16004","volume":"24","author":"Q Liu","year":"2020","unstructured":"Liu Q, Gao Y, Ou Q et al (2020) Differential expression of CD64 in patients with Mycobacterium tuberculosis infection: a potential biomarker for clinical diagnosis and prognosis. J Cell Mol Med 24:13961\u201313972. https:\/\/doi.org\/10.1111\/jcmm.16004","journal-title":"J Cell Mol Med"},{"key":"9877_CR48","doi-asserted-by":"publisher","first-page":"905060","DOI":"10.3389\/fimmu.2022.905060","volume":"13","author":"Q Liu","year":"2022","unstructured":"Liu Q, Gao Y, Yang T et al (2022) nCD64 index as a novel inflammatory indicator for the early prediction of prognosis in infectious and non-infectious inflammatory diseases: an observational study of febrile patients. Front Immunol 13:905060. https:\/\/doi.org\/10.3389\/fimmu.2022.905060","journal-title":"Front Immunol"},{"key":"9877_CR49","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1515\/cclm-2012-0279","volume":"51","author":"JH Gerrits","year":"2013","unstructured":"Gerrits JH, McLaughlin PMJ, Nienhuis BN et al (2013) Polymorphic mononuclear neutrophils CD64 index for diagnosis of sepsis in postoperative surgical patients and critically ill patients. Clin Chem Lab Med 51:897\u2013905. https:\/\/doi.org\/10.1515\/cclm-2012-0279","journal-title":"Clin Chem Lab Med"},{"key":"9877_CR50","doi-asserted-by":"publisher","first-page":"e89","DOI":"10.1515\/cclm-2014-0814","volume":"53","author":"P Rogina","year":"2015","unstructured":"Rogina P, Stubljar D, Lejko-Zupanc T et al (2015) Expression of CD64 on neutrophils (CD64 index): diagnostic accuracy of CD64 index to predict sepsis in critically ill patients. Clin Chem Lab Med 53:e89\u201391. https:\/\/doi.org\/10.1515\/cclm-2014-0814","journal-title":"Clin Chem Lab Med"},{"key":"9877_CR51","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1097\/SHK.0000000000001478","volume":"54","author":"S Duan","year":"2020","unstructured":"Duan S, Jiao Y, Wang J et al (2020) Impaired B-Cell maturation contributes to reduced B cell numbers and poor prognosis in Sepsis. Shock 54:70. https:\/\/doi.org\/10.1097\/SHK.0000000000001478","journal-title":"Shock"},{"key":"9877_CR52","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1186\/s12885-021-09023-9","volume":"21","author":"Y Wang","year":"2021","unstructured":"Wang Y, Tan H, Yu T et al (2021) The identification of gene signatures in patients with extranodal NK\/T-cell lymphoma from a pair of twins. BMC Cancer 21:1303. https:\/\/doi.org\/10.1186\/s12885-021-09023-9","journal-title":"BMC Cancer"},{"key":"9877_CR53","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1517\/14728222.2014.877891","volume":"18","author":"X Li","year":"2014","unstructured":"Li X, Kimberly RP (2014) Targeting the fc receptor in autoimmune disease. Expert Opin Ther Targets 18:335\u2013350. https:\/\/doi.org\/10.1517\/14728222.2014.877891","journal-title":"Expert Opin Ther Targets"},{"key":"9877_CR54","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/s1074-7613(02)00275-3","volume":"16","author":"H Ji","year":"2002","unstructured":"Ji H, Ohmura K, Mahmood U et al (2002) Arthritis critically dependent on innate immune system players. Immunity 16:157\u2013168. https:\/\/doi.org\/10.1016\/s1074-7613(02)00275-3","journal-title":"Immunity"},{"key":"9877_CR55","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1002\/art.10813","volume":"48","author":"K Matsumoto","year":"2003","unstructured":"Matsumoto K, Watanabe N, Akikusa B et al (2003) Fc receptor-independent development of autoimmune glomerulonephritis in lupus-prone MRL\/lpr mice. Arthritis Rheum 48:486\u2013494. https:\/\/doi.org\/10.1002\/art.10813","journal-title":"Arthritis Rheum"},{"key":"9877_CR56","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1002\/1521-4141(200002)30:2<481::AID-IMMU481>3.0.CO;2-L","volume":"30","author":"C Schiller","year":"2000","unstructured":"Schiller C, Janssen-Graalfs I, Baumann U et al (2000) Mouse Fc\u03b3RII is a negative regulator of Fc\u03b3RIII in IgG immune complex-triggered inflammation but not in autoantibody-induced hemolysis. Eur J Immunol 30:481\u2013490. https:\/\/doi.org\/10.1002\/1521-4141(200002)30:2%3C481::AID-IMMU481%3E3.0.CO;2-L","journal-title":"Eur J Immunol"},{"key":"9877_CR57","doi-asserted-by":"publisher","unstructured":"Verbeek JS, Hirose S, Nishimura H (2019) The Complex Association of Fc\u03b3RIIb With Autoimmune Susceptibility. Front Immunol 10:2061. https:\/\/doi.org\/10.3389\/fimmu.2019.02061","DOI":"10.3389\/fimmu.2019.02061"},{"key":"9877_CR58","doi-asserted-by":"publisher","first-page":"103016","DOI":"10.1016\/j.autrev.2021.103016","volume":"21","author":"E Chalayer","year":"2022","unstructured":"Chalayer E, Gramont B, Zekre F et al (2022) Fc receptors gone wrong: a comprehensive review of their roles in autoimmune and inflammatory diseases. Autoimmun Rev 21:103016. https:\/\/doi.org\/10.1016\/j.autrev.2021.103016","journal-title":"Autoimmun Rev"},{"key":"9877_CR59","doi-asserted-by":"publisher","first-page":"4030","DOI":"10.4049\/jimmunol.1500418","volume":"196","author":"S Kang","year":"2016","unstructured":"Kang S, Rogers JL, Monteith AJ et al (2016) Apoptotic debris accumulates on hematopoietic cells and promotes Disease in Murine and Human systemic lupus erythematosus. J Immunol Baltim Md 1950 196:4030\u20134039. https:\/\/doi.org\/10.4049\/jimmunol.1500418","journal-title":"J Immunol Baltim Md 1950"},{"key":"9877_CR60","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1182\/blood-2012-07-442541","volume":"121","author":"DA Mancardi","year":"2013","unstructured":"Mancardi DA, Albanesi M, J\u00f6nsson F et al (2013) The high-affinity human IgG receptor Fc\u03b3RI (CD64) promotes IgG-mediated inflammation, anaphylaxis, and antitumor immunotherapy. Blood 121:1563\u20131573. https:\/\/doi.org\/10.1182\/blood-2012-07-442541","journal-title":"Blood"},{"key":"9877_CR61","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/imr.12341","volume":"268","author":"CE Hargreaves","year":"2015","unstructured":"Hargreaves CE, Rose-Zerilli MJJ, Machado LR et al (2015) Fc\u03b3 receptors: genetic variation, function, and disease. Immunol Rev 268:6\u201324. https:\/\/doi.org\/10.1111\/imr.12341","journal-title":"Immunol Rev"},{"key":"9877_CR62","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/978-3-319-07911-0_13","volume-title":"Fc receptors","author":"X Li","year":"2014","unstructured":"Li X, Gibson AW, Kimberly RP (2014) Human FcR polymorphism and disease. In: Daeron M, Nimmerjahn F (eds) Fc receptors. Springer International Publishing, Cham, pp 275\u2013302"},{"key":"9877_CR63","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/ng.2220","volume":"44","author":"Y Onouchi","year":"2012","unstructured":"Onouchi Y, Ozaki K, Burns JC et al (2012) A genome-wide association study identifies three new risk loci for Kawasaki disease. Nat Genet 44:517\u2013521. https:\/\/doi.org\/10.1038\/ng.2220","journal-title":"Nat Genet"},{"key":"9877_CR64","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1212\/WNL.54.8.1661","volume":"54","author":"W-L van der Pol","year":"2000","unstructured":"van der Pol W-L, van den Berg LH, Scheepers RHM et al (2000) IgG receptor IIa alleles determine susceptibility and severity of Guillain-Barr\u00e9 syndrome. Neurology 54:1661\u20131665. https:\/\/doi.org\/10.1212\/WNL.54.8.1661","journal-title":"Neurology"},{"key":"9877_CR65","doi-asserted-by":"publisher","first-page":"3220","DOI":"10.1002\/art.21344","volume":"52","author":"C Tan Sardjono","year":"2005","unstructured":"Tan Sardjono C, Mottram PL, van de Velde NC et al (2005) Development of spontaneous multisystem autoimmune disease and hypersensitivity to antibody-induced inflammation in fcgamma receptor IIa-transgenic mice. Arthritis Rheum 52:3220\u20133229. https:\/\/doi.org\/10.1002\/art.21344","journal-title":"Arthritis Rheum"},{"key":"9877_CR66","doi-asserted-by":"publisher","first-page":"6591","DOI":"10.1074\/jbc.M009483200","volume":"276","author":"RL Shields","year":"2001","unstructured":"Shields RL, Namenuk AK, Hong K et al (2001) High resolution mapping of the binding site on human IgG1 for fc gamma RI, fc gamma RII, fc gamma RIII, and FcRn and design of IgG1 variants with improved binding to the fc gamma R. J Biol Chem 276:6591\u20136604. https:\/\/doi.org\/10.1074\/jbc.M009483200","journal-title":"J Biol Chem"},{"key":"9877_CR67","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1002\/art.10257","volume":"46","author":"C Kyogoku","year":"2002","unstructured":"Kyogoku C, Dijstelbloem HM, Tsuchiya N et al (2002) Fcgamma receptor gene polymorphisms in Japanese patients with systemic lupus erythematosus: contribution of FCGR2B to genetic susceptibility. Arthritis Rheum 46:1242\u20131254. https:\/\/doi.org\/10.1002\/art.10257","journal-title":"Arthritis Rheum"},{"key":"9877_CR68","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1002\/art.10122","volume":"46","author":"A Nieto","year":"2002","unstructured":"Nieto A, Pascual M, C\u00e1liz R et al (2002) Association of Fcgamma receptor IIIA polymorphism with rheumatoid arthritis: comment on the article by Morgan et al. Arthritis Rheum 46:556\u2013559. https:\/\/doi.org\/10.1002\/art.10122","journal-title":"Arthritis Rheum"},{"key":"9877_CR69","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1038\/nm1288","volume":"11","author":"RA Floto","year":"2005","unstructured":"Floto RA, Clatworthy MR, Heilbronn KR et al (2005) Loss of function of a lupus-associated Fc\u03b3RIIb polymorphism through exclusion from lipid rafts. Nat Med 11:1056\u20131058. https:\/\/doi.org\/10.1038\/nm1288","journal-title":"Nat Med"},{"key":"9877_CR70","doi-asserted-by":"publisher","unstructured":"Su K, Wu J, Edberg JC et al (2004) A promoter haplotype of the immunoreceptor tyrosine-based inhibitory motif-bearing FcgammaRIIb alters receptor expression and associates with autoimmunity. I. Regulatory FCGR2B polymorphisms and their association with systemic lupus erythematosus. J Immunol Baltim Md 1950 172:7186\u20137191. https:\/\/doi.org\/10.4049\/jimmunol.172.11.7186","DOI":"10.4049\/jimmunol.172.11.7186"},{"key":"9877_CR71","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1007\/s00439-005-1302-3","volume":"117","author":"MC Blank","year":"2005","unstructured":"Blank MC, Stefanescu RN, Masuda E et al (2005) Decreased transcription of the human FCGR2B gene mediated by the \u2013\u2009343 G\/C promoter polymorphism and association with systemic lupus erythematosus. Hum Genet 117:220\u2013227. https:\/\/doi.org\/10.1007\/s00439-005-1302-3","journal-title":"Hum Genet"},{"key":"9877_CR72","doi-asserted-by":"publisher","first-page":"2157","DOI":"10.1084\/jem.20051503","volume":"203","author":"M Mackay","year":"2006","unstructured":"Mackay M, Stanevsky A, Wang T et al (2006) Selective dysregulation of the FcgammaIIB receptor on memory B cells in SLE. J Exp Med 203:2157\u20132164. https:\/\/doi.org\/10.1084\/jem.20051503","journal-title":"J Exp Med"},{"key":"9877_CR73","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1007\/s10198-021-01290-4","volume":"22","author":"AB D\u2032Av\u00f3 Lu\u00eds","year":"2021","unstructured":"D\u2032Av\u00f3 Lu\u00eds AB, Seo MK (2021) Has the development of cancer biomarkers to guide treatment improved health outcomes? Eur J Health Econ 22:789\u2013810. https:\/\/doi.org\/10.1007\/s10198-021-01290-4","journal-title":"Eur J Health Econ"},{"key":"9877_CR74","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.clcc.2020.02.007","volume":"19","author":"A De Cuyper","year":"2020","unstructured":"De Cuyper A, Van Den Eynde M, Machiels J-P (2020) HER2 as a predictive biomarker and treatment target in Colorectal Cancer. Clin Colorectal Cancer 19:65\u201372. https:\/\/doi.org\/10.1016\/j.clcc.2020.02.007","journal-title":"Clin Colorectal Cancer"},{"key":"9877_CR75","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.intimp.2018.12.018","volume":"67","author":"X Rui","year":"2019","unstructured":"Rui X, Gu T-T, Pan H-F, Zhang H-Z (2019) Evaluation of PD-L1 biomarker for immune checkpoint inhibitor (PD-1\/PD-L1 inhibitors) treatments for urothelial carcinoma patients: a meta-analysis. Int Immunopharmacol 67:378\u2013385. https:\/\/doi.org\/10.1016\/j.intimp.2018.12.018","journal-title":"Int Immunopharmacol"},{"key":"9877_CR76","doi-asserted-by":"publisher","first-page":"962","DOI":"10.2174\/1389450121666200203162541","volume":"21","author":"A Tazzite","year":"2020","unstructured":"Tazzite A, Jouhadi H, Benider A, Nadifi S (2020) BRCA Mutational Status is a Promising Predictive Biomarker for Platinum- based Chemotherapy in Triple-negative breast Cancer. Curr Drug Targets 21:962\u2013973. https:\/\/doi.org\/10.2174\/1389450121666200203162541","journal-title":"Curr Drug Targets"},{"key":"9877_CR77","doi-asserted-by":"crossref","unstructured":"Gezici S (2024) Molecular mechanisms of Immune checkpoints as an Immunotherapy Tool in Hematological malignancies. Reference Module in Biomedical sciences. Elsevier","DOI":"10.1016\/B978-0-443-15717-2.00035-4"},{"key":"9877_CR78","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1093\/ajcp\/110.6.797","volume":"110","author":"AM Krasinskas","year":"1998","unstructured":"Krasinskas AM, Wasik MA, Kamoun M et al (1998) The usefulness of CD64, other Monocyte-Associated antigens, and CD45 Gating in the subclassification of Acute myeloid leukemias with monocytic differentiation. Am J Clin Pathol 110:797\u2013805. https:\/\/doi.org\/10.1093\/ajcp\/110.6.797","journal-title":"Am J Clin Pathol"},{"key":"9877_CR79","doi-asserted-by":"publisher","first-page":"e2020459118","DOI":"10.1073\/pnas.2020459118","volume":"118","author":"A-S Chretien","year":"2021","unstructured":"Chretien A-S, Devillier R, Granjeaud S et al (2021) High-dimensional mass cytometry analysis of NK cell alterations in AML identifies a subgroup with adverse clinical outcome. Proc Natl Acad Sci U S A 118:e2020459118. https:\/\/doi.org\/10.1073\/pnas.2020459118","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9877_CR80","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1002\/hon.2516","volume":"36","author":"A Junge","year":"2018","unstructured":"Junge A, Bacher U, Mueller BU et al (2018) Adverse outcome of AML with aberrant CD16 and CD56 NK cell marker expression. Hematol Oncol 36:576\u2013583. https:\/\/doi.org\/10.1002\/hon.2516","journal-title":"Hematol Oncol"},{"key":"9877_CR81","doi-asserted-by":"publisher","first-page":"76","DOI":"10.3389\/fimmu.2013.00076","volume":"4","author":"UJE Seidel","year":"2013","unstructured":"Seidel UJE, Schlegel P, Lang P (2013) Natural killer cell mediated antibody-dependent cellular cytotoxicity in tumor immunotherapy with therapeutic antibodies. Front Immunol 4:76. https:\/\/doi.org\/10.3389\/fimmu.2013.00076","journal-title":"Front Immunol"},{"key":"9877_CR82","doi-asserted-by":"publisher","first-page":"520","DOI":"10.3389\/fimmu.2014.00520","volume":"5","author":"G Vidarsson","year":"2014","unstructured":"Vidarsson G, Dekkers G, Rispens T (2014) IgG subclasses and allotypes: from structure to effector functions. Front Immunol 5:520. https:\/\/doi.org\/10.3389\/fimmu.2014.00520","journal-title":"Front Immunol"},{"key":"9877_CR83","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1111\/j.1365-2567.2006.02464.x","volume":"119","author":"JMH de Jong","year":"2006","unstructured":"de Jong JMH, Schuurhuis DH, Ioan-Facsinay A et al (2006) Dendritic cells, but not macrophages or B cells, activate major histocompatibility complex class II-restricted CD4\u2009+\u2009T cells upon immune-complex uptake in vivo. Immunology 119:499\u2013506. https:\/\/doi.org\/10.1111\/j.1365-2567.2006.02464.x","journal-title":"Immunology"},{"key":"9877_CR84","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/nrc.2015.5","volume":"16","author":"MG Morvan","year":"2015","unstructured":"Morvan MG, Lanier LL (2015) NK cells and cancer: you can teach innate cells new tricks. Nat Rev Cancer 16:7\u201319","journal-title":"Nat Rev Cancer"},{"key":"9877_CR85","doi-asserted-by":"publisher","first-page":"e003171","DOI":"10.1136\/jitc-2021-003171","volume":"10","author":"A Musolino","year":"2022","unstructured":"Musolino A, Gradishar WJ, Rugo HS et al (2022) Role of Fc\u03b3 receptors in HER2-targeted breast cancer therapy. J Immunother Cancer 10:e003171. https:\/\/doi.org\/10.1136\/jitc-2021-003171","journal-title":"J Immunother Cancer"},{"key":"9877_CR86","doi-asserted-by":"publisher","first-page":"3739","DOI":"10.3390\/ijms21113739","volume":"21","author":"L Hofmann","year":"2020","unstructured":"Hofmann L, Ludwig S, Schuler PJ et al (2020) The potential of CD16 on plasma-derived exosomes as a Liquid Biomarker in Head and Neck Cancer. Int J Mol Sci 21:3739. https:\/\/doi.org\/10.3390\/ijms21113739","journal-title":"Int J Mol Sci"},{"key":"9877_CR87","doi-asserted-by":"publisher","unstructured":"Wang Z, Wang Q, Qin F, Chen J (2024) Exosomes: a promising avenue for cancer diagnosis beyond treatment. Front Cell Dev Biol 12. https:\/\/doi.org\/10.3389\/fcell.2024.1344705","DOI":"10.3389\/fcell.2024.1344705"},{"key":"9877_CR88","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s12943-022-01509-9","volume":"21","author":"D Yu","year":"2022","unstructured":"Yu D, Li Y, Wang M et al (2022) Exosomes as a new frontier of cancer liquid biopsy. Mol Cancer 21:56. https:\/\/doi.org\/10.1186\/s12943-022-01509-9","journal-title":"Mol Cancer"},{"key":"9877_CR89","doi-asserted-by":"publisher","first-page":"802","DOI":"10.3390\/bios13080802","volume":"13","author":"S Sonbhadra","year":"2023","unstructured":"Sonbhadra S, Mehak, Pandey LM (2023) Biogenesis, isolation, and detection of exosomes and their potential in therapeutics and Diagnostics. Biosensors 13:802. https:\/\/doi.org\/10.3390\/bios13080802","journal-title":"Biosensors"},{"key":"9877_CR90","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1016\/j.cell.2013.04.029","volume":"153","author":"N Regev-Rudzki","year":"2013","unstructured":"Regev-Rudzki N, Wilson DW, Carvalho TG et al (2013) Cell-cell communication between malaria-infected red blood cells via exosome-like vesicles. Cell 153:1120\u20131133. https:\/\/doi.org\/10.1016\/j.cell.2013.04.029","journal-title":"Cell"},{"key":"9877_CR91","doi-asserted-by":"publisher","unstructured":"Mata-Molanes JJ, Rebollo-Liceaga J, Mart\u00ednez-Navarro EM et al (2022) Relevance of fc gamma receptor polymorphisms in Cancer Therapy with Monoclonal antibodies. Front Oncol 12. https:\/\/doi.org\/10.3389\/fonc.2022.926289","DOI":"10.3389\/fonc.2022.926289"},{"key":"9877_CR92","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/imr.12350","volume":"268","author":"P Bruhns","year":"2015","unstructured":"Bruhns P, J\u00f6nsson F (2015) Mouse and human FcR effector functions. Immunol Rev 268:25\u201351. https:\/\/doi.org\/10.1111\/imr.12350","journal-title":"Immunol Rev"},{"key":"9877_CR93","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1001\/jamaoncol.2016.4884","volume":"3","author":"PG Gavin","year":"2017","unstructured":"Gavin PG, Song N, Kim SR et al (2017) Association of Polymorphisms in FCGR2A and FCGR3A with degree of Trastuzumab Benefit in the adjuvant treatment of ERBB2\/HER2-Positive breast Cancer: analysis of the NSABP B-31 trial. JAMA Oncol 3:335\u2013341. https:\/\/doi.org\/10.1001\/jamaoncol.2016.4884","journal-title":"JAMA Oncol"},{"key":"9877_CR94","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1007\/s00277-016-2723-x","volume":"95","author":"D Liu","year":"2016","unstructured":"Liu D, Tian Y, Sun D et al (2016) The FCGR3A polymorphism predicts the response to Rituximab-based therapy in patients with non-hodgkin lymphoma: a meta-analysis. Ann Hematol 95:1483\u20131490. https:\/\/doi.org\/10.1007\/s00277-016-2723-x","journal-title":"Ann Hematol"},{"key":"9877_CR95","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1158\/2326-6066.CIR-15-0184","volume":"4","author":"AM Trotta","year":"2016","unstructured":"Trotta AM, Ottaiano A, Romano C et al (2016) Prospective evaluation of cetuximab-mediated antibody-dependent cell cytotoxicity in metastatic colorectal Cancer patients predicts treatment efficacy. Cancer Immunol Res 4:366\u2013374. https:\/\/doi.org\/10.1158\/2326-6066.CIR-15-0184","journal-title":"Cancer Immunol Res"},{"key":"9877_CR96","doi-asserted-by":"publisher","first-page":"5478","DOI":"10.1002\/cam4.1819","volume":"7","author":"D Shepshelovich","year":"2018","unstructured":"Shepshelovich D, Townsend AR, Espin-Garcia O et al (2018) Fc-gamma receptor polymorphisms, cetuximab therapy, and overall survival in the CCTG CO.20 trial of metastatic colorectal cancer. Cancer Med 7:5478\u20135487. https:\/\/doi.org\/10.1002\/cam4.1819","journal-title":"Cancer Med"},{"key":"9877_CR97","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1016\/j.ejca.2012.01.007","volume":"48","author":"J Rodr\u00edguez","year":"2012","unstructured":"Rodr\u00edguez J, Zarate R, Bandres E et al (2012) Fc gamma receptor polymorphisms as predictive markers of Cetuximab efficacy in epidermal growth factor receptor downstream-mutated metastatic colorectal cancer. Eur J Cancer 48:1774\u20131780. https:\/\/doi.org\/10.1016\/j.ejca.2012.01.007","journal-title":"Eur J Cancer"},{"key":"9877_CR98","doi-asserted-by":"publisher","first-page":"900699","DOI":"10.3389\/fphar.2022.900699","volume":"13","author":"L Li","year":"2022","unstructured":"Li L, Huang Z, Du K et al (2022) Integrative pan-cancer analysis confirmed that FCGR3A is a candidate Biomarker Associated with Tumor Immunity. Front Pharmacol 13:900699. https:\/\/doi.org\/10.3389\/fphar.2022.900699","journal-title":"Front Pharmacol"},{"key":"9877_CR99","doi-asserted-by":"publisher","unstructured":"Sun K, Fei X, Xu M et al (2022) FCGR3A Is a Prognostic Biomarker and Correlated with Immune Infiltrates in Lower-Grade Glioma. J Oncol 2022:9499317. https:\/\/doi.org\/10.1155\/2022\/9499317","DOI":"10.1155\/2022\/9499317"},{"key":"9877_CR100","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.tree.2014.11.009","volume":"30","author":"ABA Shafer","year":"2015","unstructured":"Shafer ABA, Wolf JBW, Alves PC et al (2015) Genomics and the challenging translation into conservation practice. Trends Ecol Evol 30:78\u201387. https:\/\/doi.org\/10.1016\/j.tree.2014.11.009","journal-title":"Trends Ecol Evol"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-024-09877-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-024-09877-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-024-09877-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T04:12:28Z","timestamp":1738728748000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-024-09877-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,27]]},"references-count":100,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["9877"],"URL":"https:\/\/doi.org\/10.1007\/s11033-024-09877-9","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,27]]},"assertion":[{"value":"17 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"It is not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical statements"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Institutional Review Board Statement"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no conflict of interest.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"937"}}